Equifax (EFX) stock has been moving without a clear single news catalyst, leaving investors focused on its recent share performance, current valuation signals, and the latest snapshot of its business fundamentals.

At a share price of $175.62, Equifax has seen a 1-day share price return of 1.40%. Its year to date share price return of 17.95% and 1-year total shareholder return of 34.65% indicate changing momentum following earlier weakness.

If you are assessing how Equifax fits alongside other opportunities, this is a good moment to widen your research and look through the 18 top founder-led companies

So with a share price of $175.62, recent negative multi year returns, and analyst targets and intrinsic estimates sitting higher, are you looking at an undervalued Equifax stock, or is the market already pricing in future growth?

Most Popular Narrative: 23.4% Undervalued

With Equifax last closing at $175.62 and the most followed narrative pointing to a fair value of $229.19, the gap between price and modeled worth is clear and material.

Accelerating customer adoption of new multi-data product solutions (e.g., TWN indicator, Single Data Fabric, EFX.AI) and continued high NPI (New Product Introduction) rates are expanding Equifax's value proposition, positioning the company to capture incremental market share and drive sustained organic revenue growth above historical levels.

Curious what sits behind that confidence in higher earnings power? The narrative leans heavily on faster revenue expansion, higher margins, and a richer future profit multiple. The exact mix of these assumptions is where the story really gets interesting.

Result: Fair Value of $229.19 (UNDERVALUED)

However, you also need to weigh ongoing litigation and regulatory scrutiny, along with rising competitive pressures in credit scoring, which could strain margins and earnings power in the future.

Another Angle on Valuation

The SWS DCF model presents a very different perspective compared with the earnings multiple story. At $175.62, Equifax is assessed as trading 56.2% below an estimated future cash flow value of $401.11. This suggests a much larger gap between price and modeled cash flows than earnings ratios imply. Which lens do you trust more?

Next Steps

With all this in mind, the picture on Equifax is mixed. It makes sense to move quickly, review the data yourself, and weigh both sides using the 4 key rewards and 1 important warning sign

Looking for more investment ideas?

If Equifax has sharpened your focus, do not stop here. The screener can surface other opportunities that fit your style before the market reacts.

• Target steady income by reviewing companies screened as potential high yield payers through the 12 dividend fortresses.
• Spot quality at a discount by scanning companies that appear mispriced on fundamentals using the 51 high quality undervalued stocks.
• Prioritize resilience by focusing on companies assessed to have stronger financial foundations via the solid balance sheet and fundamentals stocks screener (44 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.